| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/23/2002 | WO2001085961A3 Human caspase-12 |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001085792A8 Mu-1, member of the cytokine receptor family |
| 05/23/2002 | WO2001085768A3 G-protein coupled receptors and uses therefor |
| 05/23/2002 | WO2001085208A3 Molecular antigen arrays and vaccines |
| 05/23/2002 | WO2001083774A3 Novel mutated form of arginine deiminase |
| 05/23/2002 | WO2001083755A3 Human anti-cd40 antibodies and methods of making and using same |
| 05/23/2002 | WO2001083753A3 Molecules of the nbs/lrr protein family and uses thereof |
| 05/23/2002 | WO2001083730A3 Recombinant lentiviral vectors pseudotyped in envelopes containing filovirus binding domains |
| 05/23/2002 | WO2001083720A3 23686, a novel human aminotransferase and uses therefor |
| 05/23/2002 | WO2001083697A3 System for functional gene discovery in plants |
| 05/23/2002 | WO2001083691A3 System for identifying and analyzing expression of are-containing genes |
| 05/23/2002 | WO2001083621A3 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates |
| 05/23/2002 | WO2001083513A3 Antisense modulation of inhibitor of dna binding-1 expression |
| 05/23/2002 | WO2001081605A3 Method for the transformation of plant cell plastids |
| 05/23/2002 | WO2001081603A3 Trophic conversion of obligate phototrophic algae through metabolic engineering |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001081549A3 Hepatocyte lineage cells derived from pluripotent stem cells |
| 05/23/2002 | WO2001081411A3 Human 7-transmembrane g-protein coupled receptors and polynucleotides encoding the same |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001078753A3 Therapeutic uses for mesenchymal stromal cells |
| 05/23/2002 | WO2001076637A3 Peptide conjugates for drug delivery |
| 05/23/2002 | WO2001075149A3 Biosensor, biosensor array and method for detecting macromolecular biopolymers with a biosensor |
| 05/23/2002 | WO2001073090A3 Method for modifying lignin composition and increasing in vivo digestibility of forages |
| 05/23/2002 | WO2001073028A3 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 05/23/2002 | WO2001072294A3 Method of treating hepatitis delta viral infection |
| 05/23/2002 | WO2001068866A3 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use |
| 05/23/2002 | WO2001068826A3 Protoporphyrinogen oxidase ('protox') genes |
| 05/23/2002 | WO2001064837A8 β NETRIN AND USES THEREOF |
| 05/23/2002 | WO2001059098A3 Method for purifying nucleic acids |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001050865A3 Synergistic insect control |
| 05/23/2002 | WO2001049316A3 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 05/23/2002 | WO2001040469A3 Tick antigens and compositions and methods comprising them |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001038346A3 Short peptides to target epithelial cells |
| 05/23/2002 | WO2001029261A3 A method for high-density microarray mediated gene expression profiling |
| 05/23/2002 | WO2001029197A3 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 05/23/2002 | WO2001027289A3 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
| 05/23/2002 | WO2001026459A3 Flowering time modification |
| 05/23/2002 | WO2001020024A3 Method for determining nucleic and/or amino acid sequences |
| 05/23/2002 | WO2000066774A3 Improved assay and reagents therefor |
| 05/23/2002 | US20020062504 Nuclelotide sequences for use in the generation of plant resistant to viral diseases |
| 05/23/2002 | US20020062503 Glyphosate tolerant wheat plant 33391 and compositions and methods for detection thereof |
| 05/23/2002 | US20020062502 Transgenic plants expressing cellulolytic enzymes |
| 05/23/2002 | US20020062501 Method of growth regulation treatment of turf grass and growth-regulated turf grass |
| 05/23/2002 | US20020062500 Hypersensitive response eliciting domains and use thereof |
| 05/23/2002 | US20020062499 Methods for translational repression of gene expression in plants |
| 05/23/2002 | US20020062497 Plants with enhanced ability to produce starch and methods for obtaining them |
| 05/23/2002 | US20020062496 Adjusting concentration or composition of lignin in plant; obtain plant cells, transform cells, culture, regenerating plant and monitor lignin concentration and structure |
| 05/23/2002 | US20020062495 Modulating nitrogen metabolism in plant cells; obtain plant, transform with expression vector coding enzymatic polypeptide, culture, monitor propagants for adjustment in nitrogen metabolism |
| 05/23/2002 | US20020062494 Method for increasing transgenic biomass |
| 05/23/2002 | US20020062493 For general parasite resistance, including insect, fungi, virus, bacteria, and mites |
| 05/23/2002 | US20020062491 Method of producing primary hepatocellular carcinoma-bearing model animals |
| 05/23/2002 | US20020062490 Transgenic animal for use in the treatment of blood pressure defects |
| 05/23/2002 | US20020062489 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062319 Gene expression and evaluation system |
| 05/23/2002 | US20020062121 Perfusion apparatus and methods for pharmaceutical delivery |
| 05/23/2002 | US20020062017 Method and system for the preparation of cDNA |
| 05/23/2002 | US20020062016 Detection of Human Immunodeficiency Virus type 1 |
| 05/23/2002 | US20020062015 Nucleotide sequences coding preferential polypeptides for use in diagnosis and treatment of genetic disorders |
| 05/23/2002 | US20020062009 Monoclonal antibodies with reduced immunogenicity |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061862 Inducible nitric oxide synthase for treatment of disease |
| 05/23/2002 | US20020061861 Allows the encoded gene product to be expressed for long periods of time by delivering a non-viral, linear nucleic acid to a cell, in vivo and expressing the nucleic acid for extended periods |
| 05/23/2002 | US20020061860 Antisense oligonucleotide inhibition of specific histone deacetylase isoforms |
| 05/23/2002 | US20020061859 Antisense oligonucleotides and antibodies which inhibit its expression or biological activity |
| 05/23/2002 | US20020061850 Regulation of human transmembrane serine protease |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061593 Induction of homologous recombination in eukaryote; obtain cosmid, obtain vector with transposon, incubate in vitro, amplify cosmids, transform target cells, detect transform cells |
| 05/23/2002 | US20020061589 Method of immunotherapy; obtain electrodes, obtain waveform generator, generate electrically conductive pathways between electrodes and generator, incubate with transfer particles, transfer particles into cells with electrical pulse |
| 05/23/2002 | US20020061588 Direct, externally imposed control of nucleic acids |
| 05/23/2002 | US20020061585 Ribozymal nucleic acid |
| 05/23/2002 | US20020061582 Method of stimulating the mating of microorganisms in liquid medium |
| 05/23/2002 | US20020061581 Nuclelotide sequences coding immunoglobulin segment; for use in diagnosis and prevention of viral infection and disease |
| 05/23/2002 | US20020061579 Counter selection strategy for Gram-negative bacteria |
| 05/23/2002 | US20020061578 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering |
| 05/23/2002 | US20020061577 BMP-6 proteins |
| 05/23/2002 | US20020061576 Tissue plasminogen activator-like protease |
| 05/23/2002 | US20020061574 16658, 14223, and 16002, novel human kinases and uses therefor |
| 05/23/2002 | US20020061573 Nucleotide seqences which code enzymatic polypeptide for use in diagnosis and treatment of cell propagation defects, pain, eating, urogenital and brain disorders, cachexia and diabetes |
| 05/23/2002 | US20020061570 Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061567 Nucleotide sequences coding polypeptide for use in diagnostics, forensics, gene mapping and detection of mutation |
| 05/23/2002 | US20020061560 Nucleotide sequences for use as tools in the generation of heterologous proteinsin culture |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061557 Composition for use in the diagnosis and treatment of fertility defects, mammary gland and prostate cancers, osteoporosis, urogenital disorders and grave's disease |
| 05/23/2002 | US20020061556 Nucleotide sequences coding receptor for use in the diagnosis, treatment, drug screening and monitoring of genetic disorders and physiological defects |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061551 Nucleotide sequences coding a regulatory protein for use in the treatment of tumors, arteriosclerosis, autoimmune and diseases, blood disorders, asthma, arthritis and leukemia |
| 05/23/2002 | US20020061547 Microorganism for use in the generation of colored particle; for use in foods, cosmetics and medicine |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061539 Detecting modulators of binding protein activity; obtain test particle, incubate with binding protein, monitor test particles, determine spacial fit in binding protein, monitor activity of binding protein |
| 05/23/2002 | US20020061537 Stabilization of nucleic acid amplification cocktails |
| 05/23/2002 | US20020061534 Apparatus for use in the accurate detection of preferential particles in sample |
| 05/23/2002 | US20020061533 Method for the non-specific amplification of nucleic acid |